Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of shareholders of Inari Medical, Inc. (the "Company") was held on May 26, 2022. The final voting results for each proposal are set forth below.

1.

Each of the following Class II director nominees was elected to serve on the Company's board of directors for a three-year term expiring at the Company's 2025 annual meeting of shareholders, by the following vote:



                                   Votes Withheld
   Name of Nominee    Votes For                     Broker Non-Votes
  Dona G. Mead, Jr.   35,959,814        5,509,355      6,877,298
   Kirk Nielsen       30,381,282       11,083,496      6,881,689
  Catherine Szyman    32,369,734        9,095,044      6,881,689




2.

The shareholders ratified the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. The votes regarding this proposal were as follows:



  Votes For    Votes Against   Abstentions   Broker Non-Votes
  48,308,481      12,315         25,671             0




3.

The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in our proxy statement. The votes regarding this proposal were as follows:



  Votes For    Votes Against   Abstentions   Broker Non-Votes
  36,070,016     5,283,156       115,997        6,877,298




4.

The shareholders approved the advisory vote on the frequency of future advisory votes on executive compensation to be held every one year. The votes regarding this proposal were as follows:



  Votes For 1 yr.   Votes For 2 yr.   Votes For 3 yr.   Abstentions   Broker Non-Votes
    38,537,361          74,627           2,810,605        46,575         6,877,298

No other matters were submitted for shareholder action.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses